Pharmaco - Press Releases

Date	Title	Company
16-Jan-2020	First Mover to Game Changer’: Celltrion announces 2020-2030 strategy at the 38th J.P. Morgan Healthcare Conference	Celltrion
16-Jan-2020	JUST - EVOTEC BIOLOGICS ANNOUNCES PRODUCT DEVELOPMENT AND MANUFACTURING AGREEMENT WITH ONCORESPONSE	Evotec SE
15-Jan-2020	Statement on the Salinas-linked romaine lettuce E. coli O157:H7 outbreak and status update on investigation	U.S. Food and Drug Administration
15-Jan-2020	Scottish Medicines Consortium recommends Zytiga® (abiraterone acetate) in combination with prednisone and androgen deprivation therapy (ADT) for men with aggressive, early prostate cancer for use in NHS Scotland	The Janssen Pharmaceutical Companies of Johnson & Johnson
15-Jan-2020	bluebird bio Announces Launch in Germany of Zynteglo™ (autologous CD34+ cells encoding βA-T87Q-globin gene)	bluebird bio, Inc
15-Jan-2020	Alliance Healthcare Launches Online Portal	Alliance Healthcare
15-Jan-2020	Carterra® Closes Financing Round for Continued Growth of the LSA™ Platform for Next Generation Antibody Discovery	Carterra, Inc
15-Jan-2020	Sygnature Discovery strengthens DMPK team	Sygnature Discovery
15-Jan-2020	Windgap Medical and University of Minnesota Twin Cities Receive $3.2 Million NIH Grant to Develop Cyanide Antidote Autoinjector	Windgap Medical, Inc.
15-Jan-2020	Mark Antonacci Joins KJT Group as Executive Vice President of Commercial Operations	KJT Group, Inc.
15-Jan-2020	Astellas Completes Acquisition of Audentes Therapeutics	Astellas Pharma Inc.
15-Jan-2020	Bloom Science Granted Exclusive Option to License Microbiome-Based Technology for the Development of Novel Treatments for Multiple Neurological and Oncology Conditions	Bloom Science
15-Jan-2020	Tolero Pharmaceuticals Announces First Patient Dosed in Phase 2 Zella 202 Study of Investigational Agent Alvocidib in Patients with Relapsed or Refractory Acute Myeloid Leukemia Following Treatment with Venetoclax and HMA Combination Therapy	Tolero Pharmaceuticals, Inc.
15-Jan-2020	Inovio Welcomes Biotech Leader to its Board of Directors	Inovio Pharmaceuticals, Inc.
15-Jan-2020	NuMedii, Inc. Announces Pharmaceutical Discovery Collaboration For Ulcerative Colitis	NuMedii, Inc.
15-Jan-2020	Hoth Therapeutics Exercises Patent Licensing Option with the George Washington University to Further Develop a Therapeutic for Cancer Patients Suffering Cutaneous Changes Like Rash and Hair Loss, as Well as Other Neurogenic Inflammation Side Effects	Hoth Therapeutics, Inc.
15-Jan-2020	4SC AG: First Patient Enrolled in DONIMI Study Evaluating Domatinostat in the Neoadjuvant Setting in Melanoma	4SC AG
15-Jan-2020	Biotest AG: Biotest's CMV-specific hyperimmunoglobulin Cytotect CP Biotest receives UK marketing authorisation	Biotest AG
15-Jan-2020	Nektar Issues Statement Regarding FDA Advisory Committee Vote for Oxycodegol	Nektar Therapeutics
14-Jan-2020	Cardax, Inc. Announces Reverse Stock Split of Common Stock	Cardax, Inc.